Congestive heart failure risk factors
| Heart failure | |
| ICD-10 | I50.0 |
|---|---|
| ICD-9 | 428.0 |
| DiseasesDB | 16209 |
| MedlinePlus | 000158 |
| eMedicine | med/3552 |
| MeSH | D006333 |
| Cardiology Network |
 Discuss Congestive heart failure risk factors further in the WikiDoc Cardiology Network |
| Adult Congenital |
|---|
| Biomarkers |
| Cardiac Rehabilitation |
| Congestive Heart Failure |
| CT Angiography |
| Echocardiography |
| Electrophysiology |
| Cardiology General |
| Genetics |
| Health Economics |
| Hypertension |
| Interventional Cardiology |
| MRI |
| Nuclear Cardiology |
| Peripheral Arterial Disease |
| Prevention |
| Public Policy |
| Pulmonary Embolism |
| Stable Angina |
| Valvular Heart Disease |
| Vascular Medicine |
Template:WikiDoc Cardiology News Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Risk Factors for the Development of Heart Failure
- Demographic factors
- Age
- Gender
- Low socioeconomic status
- Lifestyle-related factors
- Tobacco and coffee consumption
- Alcohol consumption
- Dietary sodium intake
- Recreational drug use: Cocaine, methamphetamines.
- Comorbidities
- Echocardiographic factors
- Ventricular dimension
- Ventricular mass
- Diastolic filling impairment
- Pharmacological factors
- Chemotherapeutic agents
- Non-steroidal anti-inflammatory drugs
- Thiazolidinediones?
- Doxazosin
- Biochemical
- Albuminuria
- Homocysteine: Elevated plasma homocysteine levels are associated with almost a 75% increase in risk for heart failure development.
- Tumor necrosis factor-alpha (TNF-alpha): After adjustment for other risk factors, every tertile increment in tumor necrosis factor-alpha (TNF-alpha) levels was associated with a 60% increase in risk of heart failure. TNF-alpha has several negative pleiotropic effects and also negative inotropic properties that may be responsible for excessive heart failure risk. TNF-alpha is also associated with progression of heart failure.
- Interleukin-6: IL-6 is a pro-inflammatory cytokine which associated with an excessive risk of development of heart failure.
- C-reactive protein
- Insulin-like growth factor-I (IGF-I)
- Natriuretic peptides
- Genetic risk factors
Risk Factors Associated with Heart Failure Progression and Outcomes
- Clinical
- Etiology
- Age
- Gender
- Symptom duration
- NYHA class
- Weight
- Heart rate
- Mean arterial pressure
- S3 gallop
- Jugular venous pressure
- Cardiothoracic ratio
- Renal function
- Serum sodium
- Troponin T
- History of diabetes
- Anemia
- Echocardiographic
- Ejection fraction
- Exercise ejection fraction
- Ventricular dimensions
- Sphericity index
- Prolonged isovolumic relaxation
- Restrictive mitral filling
- Changes in E/A ratio
- Mitral regurgitation
- Contractile reserve
- Left ventricular mass
- Exercise Tolerance
- Exercise duration
- Peak O2 consumption
- VE/VCO2
- Anaerobic threshold 6-minute walk test
- Hemodynamics
- Cardiac index
- Pulmonary artery pressure
- Pulmonary artery wedge pressure
- Pulmonary vascular resistance
- Stroke work index
- Right atrial pressure
- A-V oxygen difference
- Coronary sinus O2 content
- Electrophysiological
- Conduction delay
- Atrial arrhythmia
- Family history of sudden death
- Presence of late potentials
- QT dispersion
- T wave alternans
- Neurohormonal
- Renin-angiotensin system
- Angiotensin II
- Aldosterone
- Plasma renin activity
- Sympathetic nervous system
- Norepinephrine
- Epinephrine
- Heart rate variability
- Norepinephrine spillover
- Natriuretic factors
- Atrial natriuretic peptide
- B-type natriuretic peptide
- N-terminal-pro-ANP
- Cytokines and others